# StoneX Group Inc.: financial statements, quarterly

SNEX · Nasdaq · CIK 913760 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/snex.md) · [Financials](/companies/snex/financials.md) · [Filings](/companies/snex/filings.md) · [Insiders](/companies/snex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [58.0 d](/filings/0000913760-25-000196.md) | [0.6](/filings/0000913760-25-000024.md) | [0.5](/filings/0000913760-25-000089.md) | [0.6](/filings/0000913760-25-000147.md) | [98.2 d](/filings/0000913760-25-000196.md) | [0.7](/filings/0000913760-26-000017.md) | [0.8](/filings/0000913760-26-000031.md) | [0.9](/filings/0000913760-26-000038.md) | [130 d](/filings/0000913760-25-000196.md) | [1.2](/filings/0000913760-26-000017.md) | [1.4](/filings/0000913760-26-000031.md) | [0.8](/filings/0000913760-26-000038.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $bn | [0.8 d](/filings/0000913760-25-000196.md) | [0.8](/filings/0000913760-25-000024.md) | [0.8](/filings/0000913760-25-000089.md) | [0.9](/filings/0000913760-25-000147.md) | [0.9 d](/filings/0000913760-25-000196.md) | [0.9](/filings/0000913760-26-000017.md) | [1.0](/filings/0000913760-26-000031.md) | [1.0](/filings/0000913760-26-000038.md) | [1.2 d](/filings/0000913760-25-000196.md) | [1.4](/filings/0000913760-26-000017.md) | [1.6](/filings/0000913760-26-000031.md) | [1.5](/filings/0000913760-26-000038.md) |
| Operating income | $bn | [(0.0) d](/filings/0000913760-24-000187.md) | [(0.0)](/filings/0000913760-25-000024.md) | [(0.0)](/filings/0000913760-25-000089.md) | [(0.0)](/filings/0000913760-25-000147.md) | [(0.0) d](/filings/0000913760-24-000187.md) | [(0.0)](/filings/0000913760-25-000024.md) | [(0.0)](/filings/0000913760-25-000089.md) | [(0.0)](/filings/0000913760-25-000147.md) | not reported | not reported | not reported | not reported |
| Interest expense | $bn | [0.3 d](/filings/0000913760-23-000159.md) | [0.2](/filings/0000913760-24-000025.md) | [0.3](/filings/0000913760-24-000094.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.0 d](/filings/0000913760-25-000196.md) | [0.0](/filings/0000913760-25-000024.md) | [0.0](/filings/0000913760-25-000089.md) | [0.0](/filings/0000913760-25-000147.md) | [0.0 d](/filings/0000913760-25-000196.md) | [0.0](/filings/0000913760-26-000017.md) | [0.0](/filings/0000913760-26-000031.md) | [0.0](/filings/0000913760-26-000038.md) | [0.0 d](/filings/0000913760-25-000196.md) | [0.0](/filings/0000913760-26-000017.md) | [0.1](/filings/0000913760-26-000031.md) | [0.0](/filings/0000913760-26-000038.md) |
| Net income | $bn | [0.1 d](/filings/0000913760-25-000196.md) | [0.1](/filings/0000913760-25-000024.md) | [0.1](/filings/0000913760-25-000089.md) | [0.1](/filings/0000913760-25-000147.md) | [0.1 d](/filings/0000913760-25-000196.md) | [0.1](/filings/0000913760-26-000017.md) | [0.1](/filings/0000913760-26-000031.md) | [0.1](/filings/0000913760-26-000038.md) | [0.1 d](/filings/0000913760-25-000196.md) | [0.1](/filings/0000913760-26-000017.md) | [0.2](/filings/0000913760-26-000031.md) | [0.1](/filings/0000913760-26-000038.md) |
| Diluted EPS | $ per share | not reported | [2.13](/filings/0000913760-25-000024.md) | [1.09](/filings/0000913760-25-000089.md) | [1.25](/filings/0000913760-25-000147.md) | not reported | [1.69](/filings/0000913760-26-000017.md) | [0.94](/filings/0000913760-26-000031.md) | [0.54](/filings/0000913760-26-000038.md) | not reported | [2.50](/filings/0000913760-26-000017.md) | [2.07](/filings/0000913760-26-000031.md) | [1.00](/filings/0000913760-26-000038.md) |
| Basic EPS | $ per share | not reported | [2.20](/filings/0000913760-25-000024.md) | [1.12](/filings/0000913760-25-000089.md) | [1.30](/filings/0000913760-25-000147.md) | not reported | [1.77](/filings/0000913760-26-000017.md) | [0.99](/filings/0000913760-26-000031.md) | [0.57](/filings/0000913760-26-000038.md) | not reported | [2.66](/filings/0000913760-26-000017.md) | [2.21](/filings/0000913760-26-000031.md) | [1.07](/filings/0000913760-26-000038.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0000913760-25-000196.md) | [1.2](/filings/0000913760-25-000024.md) | [1.3](/filings/0000913760-25-000089.md) | [1.2](/filings/0000913760-25-000147.md) | [1.3](/filings/0000913760-25-000196.md) | [1.4](/filings/0000913760-26-000017.md) | [1.3](/filings/0000913760-26-000031.md) | [1.3](/filings/0000913760-26-000038.md) | [1.6](/filings/0000913760-26-000038.md) | [1.6](/filings/0000913760-26-000017.md) | [2.1](/filings/0000913760-26-000031.md) | [2.2](/filings/0000913760-26-000038.md) |
| Total assets | $bn | [21.9](/filings/0000913760-25-000196.md) | [23.2](/filings/0000913760-24-000025.md) | [25.7](/filings/0000913760-24-000094.md) | [25.9](/filings/0000913760-24-000138.md) | [27.5](/filings/0000913760-25-000196.md) | [29.6](/filings/0000913760-25-000024.md) | [31.3](/filings/0000913760-25-000089.md) | [34.3](/filings/0000913760-25-000147.md) | [45.3](/filings/0000913760-26-000038.md) | [47.8](/filings/0000913760-26-000017.md) | [53.6](/filings/0000913760-26-000031.md) | [54.0](/filings/0000913760-26-000038.md) |
| Total liabilities | $bn | [20.6](/filings/0000913760-24-000187.md) | [21.8](/filings/0000913760-24-000025.md) | [24.1](/filings/0000913760-24-000094.md) | [24.3](/filings/0000913760-24-000138.md) | [25.8](/filings/0000913760-25-000196.md) | [27.8](/filings/0000913760-25-000024.md) | [29.4](/filings/0000913760-25-000089.md) | [32.3](/filings/0000913760-25-000147.md) | [42.9](/filings/0000913760-26-000038.md) | [45.3](/filings/0000913760-26-000017.md) | [50.9](/filings/0000913760-26-000031.md) | [51.2](/filings/0000913760-26-000038.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.4](/filings/0000913760-25-000196.md) | [1.5](/filings/0000913760-25-000089.md) | [1.5](/filings/0000913760-25-000147.md) | [1.6](/filings/0000913760-25-000147.md) | [1.7](/filings/0000913760-26-000038.md) | [1.8](/filings/0000913760-26-000031.md) | [1.9](/filings/0000913760-26-000038.md) | [2.0](/filings/0000913760-26-000038.md) | [2.4](/filings/0000913760-26-000038.md) | [2.5](/filings/0000913760-26-000031.md) | [2.7](/filings/0000913760-26-000038.md) | [2.8](/filings/0000913760-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [371 d](/filings/0000913760-25-000196.md) | [152](/filings/0000913760-25-000024.md) | [784 d](/filings/0000913760-25-000089.md) | [(622) d](/filings/0000913760-25-000147.md) | [193 d](/filings/0000913760-25-000196.md) | [(478)](/filings/0000913760-26-000017.md) | [(155) d](/filings/0000913760-26-000031.md) | [1,491 d](/filings/0000913760-26-000038.md) | [3,529 d](/filings/0000913760-25-000196.md) | [(1,262)](/filings/0000913760-26-000017.md) | [2,799 d](/filings/0000913760-26-000031.md) | [(1,208) d](/filings/0000913760-26-000038.md) |
| Capital expenditure | $m | [14.1 d](/filings/0000913760-25-000196.md) | [12.7](/filings/0000913760-25-000024.md) | [17.4 d](/filings/0000913760-25-000089.md) | [18.4 d](/filings/0000913760-25-000147.md) | [16.7 d](/filings/0000913760-25-000196.md) | [13.6](/filings/0000913760-26-000017.md) | [15.3 d](/filings/0000913760-26-000031.md) | [16.0 d](/filings/0000913760-26-000038.md) | [20.5 d](/filings/0000913760-25-000196.md) | [15.2](/filings/0000913760-26-000017.md) | [21.3 d](/filings/0000913760-26-000031.md) | [16.2 d](/filings/0000913760-26-000038.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [30.7](/filings/0000913760-24-000025.md) | [30.9](/filings/0000913760-24-000094.md) | [31.0](/filings/0000913760-24-000138.md) | [31.3](/filings/0000913760-25-000024.md) | [47.2](/filings/0000913760-25-000089.md) | [47.6](/filings/0000913760-25-000147.md) | [48.7](/filings/0000913760-26-000017.md) | [74.1](/filings/0000913760-26-000031.md) | [112](/filings/0000913760-26-000038.md) | [53.7](/filings/0000913760-26-000017.md) | [81.5](/filings/0000913760-26-000031.md) | [124](/filings/0000913760-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 120,616,735 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0000913760-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.